Skip to main content
. 2015 Jan 14;5:740. doi: 10.3389/fmicb.2014.00740

Table 5.

Treatment of the 80 patients.

Treatment Definite medical therapy No. of patients Outcome
Response n (%) Failure n (%)
Surgery (n = 3) 3 2 (66.7) 1 (33.3)
Medical treatment (n = 32) AMB 5 2 (40.0) 3 (60.0)
AMB+5-FC 14 11 (78.6) 3 (21.4)
Flu 5 5 (100.0) 0 (0)
AMB+Flu 2 2 (100.0) 0 (0)
AMB+itraconazole 1 1 (100.0) 0 (0)
AMB+5-FC+Flu 2 2 (100.0) 0 (0)
AMB+ketoconazole 1 1 (100.0) 0 (0)
AMB+5-FC+ketoconazole 1 1 (100.0) 0 (0)
AMB+5-FC+Flu+itraconazole 1 1 (100.0) 0 (0)
32 26 (81.2) 6 (18.8)
Surgery and medical treatment (n = 45) AMB 10 9 (90.0) 1 (10.0)
AMB+5-FC 11 8 (72.7) 3 (27.3)
Flu 6 6 (100.0) 0 (0)
AMB+Flu 8 8 (100.0) 0 (0)
AMB+5-FC+Flu 5 4 (80.0) 1 (20.0)
Ketoconazole 2 2 (100.0) 0 (0)
AMB+ketoconazole 1 1 (100.0) 0 (0)
AMB+5-FC+ketoconazole 1 1 (100.0) 0 (0)
AMB+Flu+itraconazole 1 1 (100.0) 0 (0)
45 40 (88.9) 5 (11.1)
Total No. 80 68 (85.0) 12 (15.0)

AMB, amphotericin B; 5-FC, 5-fluorocytosine; Flu, fluconazole.